Dale Q Rice Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rocket Lab Corp
RKLB
|
+$17.3K |
| 2 |
Palantir
PLTR
|
+$7.06K |
| 3 |
NVIDIA
NVDA
|
+$372 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Semiconductors
USD
|
+$1.23M |
| 2 |
Apple
AAPL
|
+$819K |
| 3 |
ProShares Ultra QQQ
QLD
|
+$495K |
| 4 |
iShares US Medical Devices ETF
IHI
|
+$266K |
| 5 |
Oracle
ORCL
|
+$224K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.32% |
| 2 | Consumer Discretionary | 4.57% |
| 3 | Financials | 4.37% |
| 4 | Communication Services | 4.1% |
| 5 | Industrials | 1.48% |
Similar funds
Dale Q Rice Investment Management's Q4 2025 Portfolio in Review
As of Q4 2025, Dale Q Rice Investment Management held 67 positions worth $140M, down 1.5% from $142M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Dale Q Rice Investment Management withdrew a net $4.67M in Q4 2025, closing 2 positions and reducing 38 holdings. Its most notable exit was Oracle, an estimated $224K position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Dale Q Rice Investment Management added an estimated $17.3K to Rocket Lab Corp.
- Dale Q Rice Investment Management added most to Rocket Lab Corp in Q4 2025, an estimated $17.3K increase.
- Dale Q Rice Investment Management's biggest Q4 2025 reduction was ProShares Ultra Semiconductors, cutting an estimated $1.23M.
- Dale Q Rice Investment Management fully exited Oracle in Q4 2025, selling an estimated $224K.
- Dale Q Rice Investment Management's ten largest holdings make up 73% of its $140M portfolio in Q4 2025.
- Dale Q Rice Investment Management opened 0 new positions and closed 2 in Q4 2025.
- Dale Q Rice Investment Management's portfolio value fell 1.5% quarter-over-quarter to $140M.
Based on Dale Q Rice Investment Management's 13F filing for Q4 2025, filed 30 Jan 2026.